AstraZeneca's Pascal Soriot picks up $21.5M pay package in 2020, a big haul in year marked by Covid-19 shot development
AstraZeneca’s 2020 was one for the books as the British drugmaker kept up a fervid pace with partner Oxford University to develop their adenovirus-based Covid-19 shot. In the meantime, sales growth in the US and emerging markets drove up AstraZeneca’s top line — and that proved lucrative for CEO Pascal Soriot.
Soriot bagged a 2020 compensation package worth $21.5 million in 2020, a slight increase from his 2019 total despite AstraZeneca posting 10% revenue growth on the year, according to the pharma giant’s annual report.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 102,400+ biopharma pros reading Endpoints daily — and it's free.